Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 344 entries
View as:

Effect Study of Tigecycline to Treat Severe Sepsis and Septic Shock

Phase: N/A Priority: Normal
NCT ID: NCT02191475 Org: User:
Start: 05/31/14 End: 05/31/17 Due: 05/31/18

Effect of Radiation and Its Timing on Breast Reconstruction in Chinese Patients

Phase: N/A Priority: Normal
NCT ID: NCT03743324 Org: User:
Start: 01/01/19 End: 04/01/23 Due: 04/01/24

Phase II Study on Sequential AG and FOLFIRINOX as Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05679050 Org: User:
Start: 10/01/22 End: 10/01/25 Due: 10/01/26

A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06208826 Org: User:
Start: 09/01/23 End: 09/01/28 Due: 09/01/29

Clinical Trial of Bile Etiology ,Proteomics and Metabonomics of Malignant Biliary Obstruction

Phase: N/A Priority: Normal
NCT ID: NCT01073514 Org: User:
Start: 12/31/09 End: 12/31/16 Due: 12/31/17

Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05273814 Org: User:
Start: 08/01/22 End: 02/01/24 Due: 02/01/25

The Effect of Serum Ferritin in irAE

Phase: N/A Priority: Normal
NCT ID: NCT06702566 Org: User:
Start: 07/04/24 End: 07/01/27 Due: 07/01/28

Study of DLL3-CAR-NK Cells in the Treatment of Extensive Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05507593 Org: User:
Start: 09/01/22 End: 07/01/23 Due: 07/01/24

Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT02497118 Org: User:
Start: 08/31/10 End: 06/30/15 Due: 06/30/16

Efficacy of the RayerKnife X Stereotactic Radiotherapy System in the Treatment of Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT06852001 Org: User:
Start: 03/01/25 End: 03/01/26 Due: 03/01/27

Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03950154 Org: User:
Start: 06/01/19 End: 08/01/23 Due: 08/01/24

Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02024438 Org: User:
Start: 12/31/13 End: 12/31/17 Due: 12/31/18

Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06766643 Org: User:
Start: 01/31/25 End: 12/31/26 Due: 12/31/27

Visualization Versus Intraoperative Neuromonitoring of the Recurrent Laryngeal Nerves During Thoracoscopic Esophagectomy

Phase: N/A Priority: Normal
NCT ID: NCT05199168 Org: User:
Start: 03/01/22 End: 07/01/24 Due: 07/01/25

Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06852287 Org: User:
Start: 09/01/24 End: 09/01/26 Due: 09/01/27

A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Treatment of Biliary Systemic Tumours

Phase: N/A Priority: Normal
NCT ID: NCT05644392 Org: User:
Start: 11/25/22 End: 11/25/25 Due: 11/25/26

A One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients.

Phase: N/A Priority: Normal
NCT ID: NCT02774200 Org: User:
Start: 05/31/16 End: 06/30/17 Due: 06/30/18

Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01660399 Org: User:
Start: 08/31/12 End: 12/31/16 Due: 12/31/17

CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06433362 Org: User:
Start: 06/01/24 End: 06/30/26 Due: 06/30/27

Study on Effectiveness and Safety of Hepatocellular Carcinoma Patients Treated With CyberKnife

Phase: N/A Priority: Normal
NCT ID: NCT02363218 Org: User:
Start: 05/31/14 End: 12/31/17 Due: 12/31/18

Phase 2 Multi-center Randomized Study to the Efficacy and Safety of AK105 Combined With Anrotinib Hydrochloride in Patients With Recurrent/Refractory Classical Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05683704 Org: User:
Start: 09/01/22 End: 05/31/26 Due: 05/31/27

HAIC Combined With Durvalumab, Tremelimumab and Bevacizumab as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05864755 Org: User:
Start: 06/20/23 End: 12/31/25 Due: 12/31/26

A Prospective Clinical Study to Validate a Preoperative Risk Scoring Model for LNM in GC Patients

Phase: N/A Priority: Normal
NCT ID: NCT06339307 Org: User:
Start: 02/15/24 End: 12/31/24 Due: 12/31/25

A Single-Arm, Open-Label, Phase I Study of GK01 for Advanced Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT06954558 Org: User:
Start: 03/18/25 End: 07/18/28 Due: 07/18/29

A Trial of Total Versus Partial Omentectomy for Advanced Gastric Cancer in Gastrectomy

Phase: N/A Priority: Normal
NCT ID: NCT04108494 Org: User:
Start: 01/01/19 End: 12/31/25 Due: 12/31/26